Summit Therapeutics Inc. is a biotech company developing new medicines.
Summit Therapeutics Inc. (SMMT) is expected to report earnings on Monday, October 19, 2026, after the close. Estimated release time 16:07 ET. Consensus EPS estimate is $-0.28.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-23 | Jun 2026 qtr | $-0.27 | $-0.28 | -2.0% | $0 |
| 2026-02-23 | Dec 2025 qtr | $-0.10 | $-0.29 | — | $0 |
| 2025-08-11 | Jun 2025 qtr | $-0.09 | $-0.31 | — | $0 |
| 2025-05-01 | Mar 2025 qtr | $-0.09 | $-0.07 | — | $0 |
| 2025-02-24 | Dec 2024 qtr | $-0.08 | $-0.07 | — | $0 |
| 2024-10-30 | Sep 2024 qtr | $-0.07 | $-0.06 | — | $0 |
| 2024-08-06 | Jun 2024 qtr | $-0.06 | $-0.07 | -12.5% | $0 |
| 2024-05-01 | Mar 2024 qtr | $-0.06 | $-0.05 | — | $0 |
SMMT has beaten consensus EPS in 0 of its last 2 scored quarters.
See SMMT on the live calendar →